Fulgent Genetics, Inc. — Director's Dealing 2020

Aug 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Fulgent Genetics, Inc. (FLGT)
CIK: 0001674930
Period of Report: 2020-08-03

Reporting Person: Xie Jian (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-03	Common Stock	A	200000	$0.00	Acquired	603712	Direct
2020-08-03	Common Stock	S	1976	$27.8618	Disposed	601736	Direct

Footnotes

F1: Reflects an award of restricted stock units relating to 200,000 shares of the Issuer's common stock. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after August 15, 2020, and 1/16th of such shares vesting every three months over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date.

F2: The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2019.

F3: The shares were sold in multiple transactions at prices ranging from $27.56 to $28.46, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to
provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions
were effected.